Condemned prisoners challenge execution-drug imports

Death-row prisoners have asked a U.S. judge to force the FDA to block imports of an execution drug. The legal challenge comes as long-used lethal-injection drugs become scarcer in the U.S., and prisons seek alternatives for use in executions. Report

Suggested Articles

The future may be uncertain for AZ’s Imfinzi in first-line lung cancer, but its targeted med Tagrisso now boasts a green light in that setting.

Ultragenyx is back with another FDA nod, this time for Crysvita to treat X-linked hypophosphatemia in patients one year and older.

Roche got a two pieces of good Hemlibra news early this week—and what's good for Hemlibra must be good for Roche.